We are a holding company whose operating subsidiary, Rise Smart Holdings Limited, provides educational services to local students who are seeking secondary education and higher education studies in the United Kingdom (UK), Australia, Canada and New Zealand. (Incorporated in the Cayman Islands) Our mission is to become the leading overseas studies consultancy service provider in […]

Concentra Group Holdings Parent, Inc. is a holding company.  (Incorporated in Delaware) We were founded in 1979 and have grown to be the largest provider of occupational health services in the United States by number of locations. Our national presence enables us to provide access to high-quality care that supports our mission to improve the […]

We are a newly organized blank check company. (Incorporated in the Cayman Islands) We expect to focus on a target in an industry where we believe our management team’s and our affiliates’ expertise will provide us with a competitive advantage, including the financial services, healthcare, real estate services, technology and software industries. (Note: CF Acquisition […]

We intend to focus our search for acquisition targets on the healthcare sector. We will concentrate on life sciences companies.     (Note: Launch One Acquisition Corp. priced its SPAC IPO in sync with the terms in its prospectus – 20.0 million units at $10.00 each – to raise $200.0 million on July 11, 2024. Each […]

Note: Veg House Holdings withdrew its IPO plans in an SEC filing dated June 13, 2024. We are a Cayman Islands holding company focused on expanding access to plant-based food products by developing a global portfolio of businesses that offer high-quality plant-based products and bridging the gap between two multi-billion-dollar industries: e-commerce and plant-based foods. […]

We are a clinical biotech company developing GSK-3 inhibitor drugs to treat metastatic pancreatic cancer. (Incorporated in Delaware) We are focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). We are developing elraglusib (formerly 9-ING-41), a small molecule that is designed to […]

Note: This IPO is part of a dual listing planned by Breathe BioMedical Inc. From the prospectus: “We intend to apply to list our common shares on the Nasdaq Capital Market under the symbol “BRTH.” We also intend to apply to list our common shares on a Canadian stock exchange (a “Canadian Exchange”) under the symbol […]

We are the holding company whose subsidiaries operate a parking technology business. (Incorporated in the Cayman Islands) We are a leading equipment supplier in China’s active parking utilization service market in terms of number of parking hardware shipments and profitability, according to Frost & Sullivan. We started our business in 2012 and has been focused […]

Our mission is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Our name, Alumis, captures our mission to enlighten immunology, and is inspired by the words “allumer”—French for illuminate—and “immunis”—Latin for the immune system. We are a clinical stage biopharmaceutical company with an initial focus on developing our two […]

We intend to focus our search for a target business in the broadly defined energy industry, primarily targeting the upstream exploration and production sector. (Incorporated in the Cayman Islands) Our sponsor is an affiliate of the EQV Group, a group of companies focused on the acquisition, management and optimization of predictable cash-flowing asset bases across the […]